Review ArticleSystematic Review

Effects of Self-Management Interventions in People With Interstitial Lung Disease

Steve Freitas Dos Santos, Alda Marques, Patrícia Rebelo, Dina Brooks, Adam Benoit and Ana Oliveira
Respiratory Care January 2024, 69 (1) 114-127; DOI: https://doi.org/10.4187/respcare.11298

REFERENCES

  1. 1.↵
    1. Aronson KI,
    2. Danoff SK,
    3. Russell AM,
    4. Ryerson CJ,
    5. Suzuki A,
    6. Wijsenbeek MS,
    7. et al
    . Patient-centered outcomes research in interstitial lung disease: An official American Thoracic Society research statement. Am J Respir Crit Care Med 2021;204(2):E3–E23.
    OpenUrl
  2. 2.↵
    1. Lee JYT,
    2. Tikellis G,
    3. Corte TJ,
    4. Goh NS,
    5. Keir GJ,
    6. Spencer L,
    7. et al
    . The supportive care needs of people living with pulmonary fibrosis and their caregivers: a systematic review. Eur Respir Rev 2020;29(156):1–12.
    OpenUrlCrossRef
  3. 3.↵
    1. Kreuter M,
    2. Swigris J,
    3. Pittrow D,
    4. Geier S,
    5. Klotsche J,
    6. Prasse A,
    7. et al
    . Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: Insights-IPF registry. Respir Res 2017;18(139):1–10.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Lee JYT,
    2. Tikellis G,
    3. Khor YH,
    4. Holland AE
    . Developing a self-management package for pulmonary fibrosis: an international Delphi study. ERJ Open Res 2022;8(4):1–11.
    OpenUrl
  5. 5.↵
    1. Taylor SJ,
    2. Pinnock H
    . Supported self-management for respiratory conditions in primary care. Prim Care Respir 2017;4(3):11–15.
    OpenUrl
  6. 6.↵
    1. Van De Velde D,
    2. De Zutter F,
    3. Satink T,
    4. Costa U,
    5. Janquart S,
    6. Senn D,
    7. De Vriendt P
    . Delineating the concept of self-management in chronic conditions: a concept analysis. BMJ Open 2019;9(7):e027775–15.
    OpenUrlPubMed
  7. 7.↵
    1. Meghji J,
    2. Mortimer K,
    3. Agusti A,
    4. Allwood BW,
    5. Asher I,
    6. Bateman ED,
    7. et al
    . Improving lung health in low-income and middle-income countries: from challenges to solutions. Lancet 2021;397(10277):928–940.
    OpenUrlPubMed
  8. 8.
    World Health Organization. Health workforce requirements for universal health coverage and the sustainable development goals (Human Resources for Health Observer, 17), 2016.
  9. 9.↵
    1. Wijsenbeek MS,
    2. Moor CC,
    3. Johannson KA,
    4. Jackson PD,
    5. Khor YH,
    6. Kondoh Y,
    7. et al
    . Home monitoring in interstitial lung diseases. Lancet Respir Med 2022;11(1):97–110.
    OpenUrl
  10. 10.↵
    1. Newham JJ,
    2. Presseau J,
    3. Heslop-Marshall K,
    4. Russell S,
    5. Ogunbayo OJ,
    6. Netts P,
    7. et al
    . Features of self-management interventions for people with COPD associated with improved health-related quality of life and reduced emergency department visits: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 2017;2017(;12):1705–1720.
    OpenUrl
  11. 11.
    1. Panagioti M,
    2. Richardson G,
    3. Small N,
    4. Murray E,
    5. Rogers A,
    6. Kennedy A,
    7. et al
    . Self-management support interventions to reduce health care utilization without compromising outcomes: a systematic review and meta-analysis. BMC Health Serv Res 2014;14:1–14.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Pinnock H,
    2. Parke HL,
    3. Panagioti M,
    4. Daines L,
    5. Pearce G,
    6. Epiphaniou E,
    7. et al
    ; PRISMS and RECURSIVE groups. Systematic meta-review of supported self-management for asthma: a health care perspective. BMC Med 2017;15(1):64–32.
    OpenUrlPubMed
  13. 13.↵
    1. Schrijver J,
    2. Lenferink A,
    3. Brusse-Keizer M,
    4. Zwerink M,
    5. van der Valk P,
    6. van der Palen J,
    7. Effing TW
    . Self-management for people with chronic obstructive pulmonary disease (review). Cochrane Database Syst Rev 2022;1(1):1–189.
    OpenUrl
  14. 14.↵
    1. Hodkinson A,
    2. Bower P,
    3. Grigoroglou C,
    4. Zghebi SS,
    5. Pinnock H,
    6. Kontopantelis E,
    7. Panagioti M
    . Self-management interventions to reduce healthcare use and improve quality of life among patients with asthma: systematic review and network meta-analysis. BMJ 2020;370(m2521):1–12.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Zibrak JD,
    2. Price D
    . Interstitial lung disease: Raising the index of suspicion in primary care. NPJ Prim Care Respir Med 2014;24(14054):1–4.
    OpenUrl
  16. 16.↵
    1. Lee JYT,
    2. Tikellis G,
    3. Glaspole I,
    4. Khor YH,
    5. Symons K,
    6. Holland AE
    . Self-management for pulmonary fibrosis: insights from people living with the disease and health care professionals. Patient Educ Couns 2022;105(4):956–964.
    OpenUrl
  17. 17.↵
    1. Trappenburg J,
    2. Jonkman N,
    3. Jaarsma T,
    4. van Os-Medendorp H,
    5. Kort H,
    6. de Wit N,
    7. et al
    . Self-management: one size does not fit all. Patient Educ Couns 2013;92(1):134–137.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Coster S,
    2. Norman I
    . Cochrane reviews of educational and self-management interventions to guide nursing practice: a review. Int J Nurs Stud 2009;46(4):508–528.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Fredericks S,
    2. Lapum J,
    3. Schwind J,
    4. Beanlands H,
    5. Romaniuk D,
    6. McCay E
    . Discussion of patient-centered care in health care organizations. Qual Manag Health Care 2012;21(3):127–134.
    OpenUrlPubMed
  20. 20.↵
    1. Aronson KI,
    2. Suzuki A
    . Health-related quality of life in interstitial lung disease: can we use the same concepts around the world? Front Med (Lausanne) 2021;8(745908):745908–745912.
    OpenUrl
  21. 21.↵
    1. Page MJ,
    2. Moher D,
    3. Bossuyt PM,
    4. Boutron I,
    5. Hoffmann TC,
    6. Mulrow CD,
    7. et al
    . PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews. BMJ 2021;372(n160):1–36.
    OpenUrlCrossRef
  22. 22.↵
    1. Higgins JPT,
    2. Thomas J,
    3. Chandler J,
    4. Cumpston M,
    5. Li T,
    6. Page MJ,
    7. Welch VA
    . Cochrane Handbook for Systematic Reviews of Interventions, 2nd edition: Wiley-Blackwell; 2019.
  23. 23.↵
    1. Collard HR,
    2. Ryerson CJ,
    3. Corte TJ,
    4. Jenkins G,
    5. Kondoh Y,
    6. Lederer DJ,
    7. et al
    . Acute exacerbation of idiopathic pulmonary fibrosis: an International Working Group Report. Am J Respir Crit Care Med 2016;194(3):265–275.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Effing TW,
    2. Vercoulen JH,
    3. Bourbeau J,
    4. Trappenburg J,
    5. Lenferink A,
    6. Cafarella P,
    7. et al
    . Definition of a COPD self-management intervention: International Expert Group consensus. Eur Respir J 2016;48(1):46–54.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Sunjaya AP,
    2. Sengupta A,
    3. Martin A,
    4. di Tanna GL,
    5. Jenkins C
    . Efficacy of self-management mobile applications for patients with breathlessness: systematic review and quality assessment of publicly available applications. Respir Med 2022;201(106947):1–12.
    OpenUrl
  26. 26.↵
    1. Newman S,
    2. Steed L,
    3. Mulligan K
    . Self-management interventions for chronic illness. Lancet 2004;364(9444):1523–1537.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Song X,
    2. Hallensleben C,
    3. Zhang W,
    4. Jiang Z,
    5. Shen H,
    6. Gobbens RJJ,
    7. et al
    . Blended Self-management interventions to reduce disease burden in patients with chronic obstructive pulmonary disease and asthma: Systematic review and meta-analysis. J Med Internet Res 2021;23(3):1–19.
    OpenUrlCrossRef
  28. 28.↵
    1. Jolly K,
    2. Sidhu MS,
    3. Bates E,
    4. Majothi S,
    5. Sitch A,
    6. Bayliss S,
    7. et al
    . Systematic review of the effectiveness of community-based self-management interventions among primary care COPD patients. NPJ Prim Care Respir Med 2018;28(44):1–8.
    OpenUrl
  29. 29.↵
    1. Lindell KO,
    2. Klein SJ,
    3. Veatch MS,
    4. Gibson KF,
    5. Kass DJ,
    6. Nouraie M,
    7. Rosenzweig MQ
    . Nurse-led palliative care clinical trial improves knowledge and preparedness in caregivers of patients with idiopathic pulmonary fibrosis. Ann Am Thorac Soc 2021;18(11):1811–1821.
    OpenUrlPubMed
  30. 30.↵
    1. Moor CC,
    2. Mostard RLM,
    3. Grutters JC,
    4. Bresser P,
    5. Aerts JGJV,
    6. Chavannes NH,
    7. Wijsenbeek MS
    . Home monitoring in patients with idiopathic pulmonary fibrosis: a randomized controlled trial. Am J Respir Crit Care Med 2020;202(3):393–401.
    OpenUrlPubMed
  31. 31.↵
    1. Ouzzani M,
    2. Hammady H,
    3. Fedorowicz Z,
    4. Elmagarmid A
    . Rayyan—a web and mobile app for systematic reviews. Syst Rev 2016;5(1):1–10.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Sterne JAC,
    2. Savović J,
    3. Page MJ,
    4. Elbers RG,
    5. Blencowe NS,
    6. Boutron I,
    7. et al
    . RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ 2019;366(l4898):1–8.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Ahn E,
    2. Kang H
    . Introduction to systematic review and meta-analysis. Korean J Anesthesiol 2018;71(2):103–112.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Harbord RM,
    2. Harris RJ,
    3. Sterne JAC
    . Updated tests for small-study effects in meta-analyses. Stata J 2009;9(2):197–210.
    OpenUrlCrossRefWeb of Science
  35. 35.↵
    1. Schunemann H,
    2. Brożek J,
    3. Guyatt G,
    4. Oxman A
    . GRADE Handbook - handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach, 2013
  36. 36.↵
    Cochrane. Review manager (RevMan) Available at: https://revman.cochrane.org.
  37. 37.↵
    1. Du Prel JB,
    2. Hommel G,
    3. Röhrig B,
    4. Blettner M
    . Confidence interval or P value? Dtsch Arztebl Int 2009;106(19):335–339.
    OpenUrlPubMed
  38. 38.↵
    1. Campbell M,
    2. McKenzie JE,
    3. Sowden A,
    4. Katikireddi SV,
    5. Brennan SE,
    6. Ellis S,
    7. et al
    . Synthesis without meta-analysis (SWiM) in systematic reviews: Reporting guideline. BMJ 2020;368(l6890):1–6.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Boon MH,
    2. Thomson H
    . The effect direction plot revisited: application of the 2019 Cochrane Handbook guidance on alternative synthesis methods. Res Synth Methods 2021;12(1):29–33.
    OpenUrl
  40. 40.↵
    1. McHugh ML
    . Interrater reliability: the kappa statistic. Biochem Med 2012;22(3):276–282.
    OpenUrlPubMed
  41. 41.↵
    1. Hancock M,
    2. Kent P
    . Interpretation of dichotomous outcomes: risk, odds, risk ratios, odds ratios, and number needed to treat. J Physiother 2016;62(3):172–174.
    OpenUrlPubMed
  42. 42.↵
    1. Cohen J
    . A power primer. Psychol Bull 1992;112(1):155–159.
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    1. Lindell KO,
    2. Olshansky E,
    3. Song M-K,
    4. Zullo TG,
    5. Gibson KF,
    6. Kaminski N,
    7. Hoffman LA
    . Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners. Heart Lung 2010;39(4):304–313.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    1. Khor YH,
    2. Saravanan K,
    3. Holland AE,
    4. Lee JYT,
    5. Ryerson CJ,
    6. McDonald CF,
    7. Goh NSL
    . A mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease. Sci Rep 2021;11(6874):1–8.
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. Jonkman NH,
    2. Schuurmans MJ,
    3. Groenwold RHH,
    4. Hoes AW,
    5. Trappenburg JCA
    . Identifying components of self-management interventions that improve health-related quality of life in chronically ill patients: systematic review and meta-regression analysis. Patient Educ Couns 2016;99(7):1087–1098.
    OpenUrlPubMed
  46. 46.↵
    1. Flather MD,
    2. Farkouh ME,
    3. Pogue JM,
    4. Yusuf S
    . Strengths and limitations of meta-analysis: larger studies may be more reliable. Control Clin Trials 1997;18(6):568–579.
    OpenUrlCrossRefPubMedWeb of Science
  47. 47.↵
    1. Davey J,
    2. Turner RM,
    3. Clarke MJ,
    4. Higgins JP
    . Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis. BMC Med Res Methodol 2011;11(160):1–11.
    OpenUrlCrossRefPubMed
  48. 48.↵
    1. Zwerink M,
    2. Brusse-Keizer M,
    3. van der Valk P,
    4. Zielhuis GA,
    5. Monninkhof EM,
    6. van der Palen J,
    7. et al
    . Self-management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2014;3(CD002990):1–118.
    OpenUrl
  49. 49.↵
    1. Schuurmans H,
    2. Steverink N,
    3. Frieswijk N,
    4. Buunk BP,
    5. Slaets JPJ,
    6. Lindenberg S
    . How to measure self-management abilities in older people by self-report. The development of the SMAS-30. Qual Life Res 2005;14(10):2215–2228.
    OpenUrlCrossRefPubMedWeb of Science
  50. 50.↵
    1. Roberts NJ,
    2. Kidd L,
    3. Dougall N,
    4. Patel IS,
    5. McNarry S,
    6. Nixon C
    . Measuring patient activation: the utility of the patient activation measure within a UK context—results from four exemplar studies and potential future applications. Patient Educ Couns 2016;99(10):1739–1746.
    OpenUrlPubMed
  51. 51.↵
    1. Jonkman NH,
    2. Schuurmans MJ,
    3. Jaarsma T,
    4. Shortridge-Baggett LM,
    5. Hoes AW,
    6. Trappenburg JCA
    . Self-management interventions: proposal and validation of a new operational definition. J Clin Epidemiol 2016;80:34–42.
    OpenUrlPubMed
  52. 52.↵
    1. Kawano-Dourado L,
    2. Glassberg MK,
    3. Assayag D,
    4. Borie R,
    5. Johannson KA
    . Sex and gender in interstitial lung diseases. Eur Respir Rev 2021;30(210105):1–12.
    OpenUrlCrossRef
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords